Influx Healthtech Limited (NSE:INFLUX)
India · Delayed Price · Currency is INR 256.00
-4.20 (-1.61%)
At close: Oct 1, 2026
Influx Healthtech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,468 | 1,049 | 999.65 | 760.57 | 592.02 |
Other Revenue | 0 | - | - | - | - |
| 1,468 | 1,049 | 999.65 | 760.57 | 592.02 | |
Revenue Growth | 40.04% | 4.89% | 31.44% | 28.47% | - |
Cost of Revenue | 878.04 | 639.48 | 656.01 | 528.63 | 456.38 |
Gross Profit | 590.3 | 409.05 | 343.65 | 231.94 | 135.64 |
Selling, General & Admin | 132.36 | 100.29 | 82.21 | 61.45 | 39.8 |
Other Operating Expenses | 158.99 | 102.06 | 91.61 | 63.25 | 34.15 |
Operating Expenses | 329.13 | 230.6 | 192.36 | 134.08 | 75.16 |
Operating Income | 261.17 | 178.46 | 151.28 | 97.86 | 60.48 |
Interest Expense | -1.84 | -0.01 | -1.71 | -0.1 | -0.05 |
Interest & Investment Income | 1.67 | 0.56 | 0.23 | - | - |
Currency Exchange Gain (Loss) | 0.07 | -0.22 | 0.01 | - | - |
Other Non Operating Income (Expenses) | - | 0 | -0.48 | -0.4 | -0.37 |
EBT Excluding Unusual Items | 261.06 | 178.79 | 149.33 | 97.36 | 60.06 |
Gain (Loss) on Sale of Investments | 11.25 | - | - | - | - |
Pretax Income | 272.31 | 178.79 | 149.33 | 97.36 | 60.06 |
Income Tax Expense | 66.92 | 45.13 | 38.05 | 25.4 | 15.69 |
Net Income | 205.39 | 133.66 | 111.28 | 71.96 | 44.37 |
Net Income to Common | 205.39 | 133.66 | 111.28 | 71.96 | 44.37 |
Net Income Growth | 53.66% | 20.11% | 54.63% | 62.20% | - |
Shares Outstanding (Basic) | 22 | 18 | 18 | 18 | 18 |
Shares Outstanding (Diluted) | 22 | 18 | 18 | 18 | 18 |
Shares Change | 21.06% | - | - | -0.00% | 0.00% |
EPS (Basic) | 9.35 | 7.36 | 6.13 | 3.96 | 2.44 |
EPS (Diluted) | 9.35 | 7.36 | 6.13 | 3.96 | 2.44 |
EPS Growth | 27.01% | 20.06% | 54.80% | 62.00% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -206.75 | -11.55 | 5.83 | 19.43 | 0.49 |
Free Cash Flow Per Share | -9.41 | -0.64 | 0.32 | 1.07 | 0.03 |
Gross Margin | 40.20% | 39.01% | 34.38% | 30.50% | 22.91% |
Operating Margin | 17.79% | 17.02% | 15.13% | 12.87% | 10.22% |
Profit Margin | 13.99% | 12.75% | 11.13% | 9.46% | 7.49% |
Free Cash Flow Margin | -14.08% | -1.10% | 0.58% | 2.55% | 0.08% |
EBITDA | 298.85 | 206.63 | 169.74 | 107.19 | 61.7 |
EBITDA Margin | 20.35% | 19.71% | 16.98% | 14.09% | 10.42% |
D&A For EBITDA | 37.68 | 28.17 | 18.46 | 9.33 | 1.22 |
EBIT | 261.17 | 178.46 | 151.28 | 97.86 | 60.48 |
EBIT Margin | 17.79% | 17.02% | 15.13% | 12.87% | 10.22% |
Effective Tax Rate | 24.57% | 25.24% | 25.48% | 26.09% | 26.13% |
Revenue as Reported | 1,482 | 1,050 | 1,000 | 760.57 | 592.02 |
Advertising Expenses | 1.61 | 0.19 | 0.2 | 1.25 | 0.14 |